Testosterone therapy has become a significant intervention in addressing various health conditions, ranging from puberty disorders to hypogonadal men and andropause management. While it has shown transformative benefits for many, concerns regarding its misuse and potential hazards have sparked controversies. This chapter delves into the multifaceted landscape of testosterone therapy, particularly focusing on its impact on cardiovascular health, benign prostatic hyperplasia (BPH), prostate cancer risk, male breast cancer, red blood cell count, and obstructive sleep apnea (OSA). The discussion on testosterone therapy’s cardiovascular effects reveals a complex narrative, with studies showing conflicting evidence regarding its association with cardiovascular risk factors, coronary heart disease, metabolic conditions, and acute clinical outcomes. Similarly, the chapter explores the relationship between testosterone levels and prostate cancer risk, highlighting contradictory findings regarding the impact of both elevated and lower testosterone levels on prostate cancer development. Furthermore, the chapter discusses the implications of testosterone replacement therapy (TRT) in managing BPH and prostate cancer, emphasizing the need for cautious consideration and vigilant monitoring. It also addresses the potential risks of TRT, including polycythemia and exacerbation of OSA symptoms, underscoring the importance of proactive management and patient counseling. In navigating the complex landscape of testosterone therapy, a balanced approach is crucial, considering both its benefits and potential hazards. While TRT holds promise in improving quality of life for many individuals, careful patient selection and monitoring are imperative to mitigate risks and optimize outcomes. Future research endeavors will continue to shape our understanding of testosterone therapy’s nuanced effects, guiding its judicious use in clinical practice.